Skip to main content
GL Pharm Tech Corp. logo

GL Pharm Tech Corp. — Investor Relations & Filings

Ticker · 204840 ISIN · KR7204840003 KO Manufacturing
Open in API
Filings indexed 260 across all filing types
Latest filing 2025-05-12 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 204840

About GL Pharm Tech Corp.

http://www.glpt.co.kr/

GL Pharm Tech Corp. is a pharmaceutical company specializing in the development of incrementally modified drugs (IMDs). The company focuses on creating improved versions of existing pharmaceutical products by utilizing advanced drug formulation and delivery technologies. Its core mission is to enhance the therapeutic value and safety of marketed drugs, with a specific emphasis on reducing side effects and improving patient convenience. GL Pharm Tech is actively engaged in research and development, managing a pipeline of drug candidates and conducting clinical trials to support the commercialization of its enhanced pharmaceutical products.

Recent filings

Filing Released Lang Actions
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 1% confidence The document is a '분기보고서' (Quarterly Report) for the 1st quarter of 2025, covering the period from 2025-01-01 to 2025-03-31. It contains detailed financial information, business operations, and management disclosures, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2025
2025-05-12 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting, including financial statement approval, dividend decisions, board member appointments, and business purpose changes. This is a formal report of the voting outcomes from an AGM, which aligns perfectly with the 'DVA' (Declaration of Voting Results) category.
2025-03-26 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 1% confidence The document is a formal regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). It details the changes in the board of directors, specifically the appointment of an outside director. This falls directly under the category of Board/Management Information (MANG).
2025-03-26 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 1% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) submitted to the Financial Supervisory Service/Korea Exchange. It details the issuance of stock options to specific individuals, including the number of shares, exercise price, and legal basis. This type of disclosure regarding capital structure changes and equity-based compensation does not fit into the specific categories of M&A, dividends, or director dealings, and is best classified as a general regulatory filing.
2025-03-26 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a formal regulatory filing submitted to the Korea Exchange (KRX) titled '감사보고서 제출' (Submission of Audit Report). It provides the audit opinion, financial highlights (assets, liabilities, equity, profit/loss), and details regarding the external auditor for the fiscal year. While it contains financial data, it is a summary disclosure of the audit results rather than the full 10-K annual report or a standalone audit report document. In the context of Korean regulatory filings (DART/KIND), this is classified as an Audit Report/Information filing. FY 2024
2025-03-18 Korean
사업보고서 (2024.12)
Annual Report Classification · 1% confidence The document is a 'Business Report' (사업보고서) for the 11th fiscal year (2024) of GL PharmTech. It contains comprehensive financial data, company history, management information, and operational details, which is the standard format for an Annual Report in the South Korean regulatory context (equivalent to a 10-K). FY 2024
2025-03-18 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.